Museum study shows human impact on chipmunks and voles in Chicago
'The oldest ones we have are from 1891, and these were collected in Jackson Park over 100 years ago,' Smith said, pointing to the two chipmunks. 'You can see how good-looking they both look, and that's the beauty of this collection. We preserve this material to last, generation to generation.'
In many ways, these well-preserved chipmunks mirror those that Chicagoans might see scurrying down alleyways or hopping around in parks today, with their distinctive white stripes and bushy tails.
But according to a new study by Field Museum researchers, Chicago's modern-day rodents have evolved to look quite different from what they did just a century ago — mostly because of human development.
Smith, along with assistant curator of mammals Anderson Feijó and two Field Museum interns, measured the skulls of nearly 400 rodent specimens — collected from the 1890s to modern day — to see how their skull structure had changed over time. The study, published June 26, focused on chipmunks and voles, aiming to compare the evolution of above- and below-ground species.
They found that over time, Chicago chipmunks have overall gotten larger, but the row of teeth along the side of their jaw has gotten smaller.
'It's probably related to the food they're eating,' Feijó said. 'Chipmunks are much more interactive with humans and have access to different kinds of food we eat. So we hypothesize they are eating more soft food and because they require less bite force, which reflects in the tooth rows.'
In vole samples, they found that the animals' size had stayed pretty consistent — but that the bumps in their skull that house the inner ear had shrunk. As Chicago grew over the past hundred years, the voles may have adapted to have smaller ears in order to protect them from the noisy city streets, Smith said.
'These two animals are small mammals, so people might sort of put them in the same category in their heads, right?' she said. 'But they're responding to this human alteration of the landscape in different ways. So preservation of natural populations of animals is not a one-size-fits-all thing … as the city changes, as we try and facilitate the longevity of green areas where these animals live, maybe we need to think about different solutions for different animals.'
During the 20th century, Chicago was one of the fastest growing cities in the world, expanding from 516,000 residents in the 1910 census to 3.5 million residents by the 1950 census. With this rapid population growth also came rapid urbanization, as buildings, highways and transit grew more and more dense. While just 6% of land in the Chicago area was used for urban development in 1900, this grew to 34% by 1992, according to data compiled by the U.S. Geological Survey and the Illinois Department of Natural Resources.
With fewer natural areas in the region, native rodents like chipmunks and voles have had to adapt to urban environments and find new sources of food and shelter. The Field Museum team used satellite imagery dating back to 1940 to determine how much of each rodent's habitat had been used for urban buildings at the time that they lived.
'These kinds of adaptations are happening across all different animals, different groups, different areas,' Feijo said. 'It's just a way that animals need to figure out how to survive these new conditions.'
Similar trends have been documented in other major cities. A 2020 study of rats in New York City found that these East Coast rodents' teeth have also shrunk over time, similar to those of Chicago chipmunks.
The Field Museum houses over 40 million mammal specimens in its archives, mostly collected in Chicago and the surrounding region, enabling scientists to track how different species have changed over time. The museum's exhibits represent less than 1% of its actual collections, according to museum communications manager Kate Golembiewski.
In addition to manually measuring the chipmunks' and voles' skulls, researchers also created 3D scans of some of the specimens, which allowed them to more closely compare the differences between each specimens' bone structure.
Moving forward, Smith and Feijo hope to use their data to find a stronger correlation between evolutionary change and urbanization.
'These animals, the fact that they are adapting and still relatively abundant shows that they are changing,' Smith said. 'But that doesn't mean that they're gonna be able to do that forever. So it's important to keep an ear to the ground, and try to understand what these guys are up to.'
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Starbase injury rates outpace rivals as SpaceX chases its Mars moonshot
SpaceX employees are more likely to be injured while working at Starbase than any of its other manufacturing facilities, according to company worker safety records reviewed by TechCrunch. Starbase, a sprawling launch-and-manufacturing site that recently incorporated as its own Texas city, logged injury rates almost six times higher than the average for comparable space vehicle manufacturing outfits and nearly three times higher than aerospace manufacturing as a whole in 2024, according to Occupational Safety and Health Administration (OSHA) data released in May. That outsized injury rate has persisted since 2019, when SpaceX began sharing Starbase injury data with the federal regulator. Starbase is home to SpaceX's most ambitious program: a fully reusable, ultra-heavy-lift rocket called Starship. The company has been moving at a breakneck pace to bring Starship online to launch Starlink internet satellites and other payloads. Since Starship's first orbital test in April 2023, SpaceX has attempted eight additional integrated flights. During three of those tests, the company made history by catching the massive Super Heavy booster with 'chopstick' arms attached to the launch tower. The data suggests that SpaceX's rapid progress comes at a cost. And while injury rates alone don't provide a complete picture of the safety culture at Starbase, they do offer a rare glimpse into the working conditions of the world's leading space company. Breaking down Starbase numbers OSHA uses a standardized safety metric called Total Recordable Incident Rate (TRIR) to measure a company's safety record and compare it to industry peers, like Blue Origin and United Launch Alliance. The publicly available data has limitations. It doesn't distinguish between minor injuries like stitches versus serious incidents such as amputations. TechCrunch calculated the TRIR based on that data, which includes the total number of incidents and total number of hours worked by SpaceX employees at each site. Starbase, which plays a central role in SpaceX CEO Elon Musk's mission to make life multi-planetary, is an outlier in the company and across the industry as a whole. Its TRIR topped out at 4.27 injuries per 100 workers in 2024, when it employed an average of 2,690 workers, according to the data submitted to OSHA. Injured Starbase employees were unable to perform their normal job duties for a total of 3,558 restricted-duty days, plus 656 lost-time days where injuries made them unable to work at all. Starbase is classified by the U.S. government as a space vehicle manufacturing operation. The injury rate in this sector has fallen dramatically since 1994, dropping from 4.2 injuries per 100 workers to 0.7 injuries per 100 workers in 2023, according to historical data from the Bureau of Labor Statistics. (BLS calculates these rates through its annual company surveys, which asks for the same information found in OSHA's worker injury forms.) But despite major changes in safety processes across the industry, Starbase is closer to the rates of 30 years ago. The injury rate across all of SpaceX's manufacturing facilities — which includes an engine development and testing site in McGregor, Texas; a Starlink satellite manufacturing complex in Bastrop, Texas; the Falcon rocket complex in Hawthorne, California; and another satellite manufacturing site in Redmond, Washington — is 2.28. These other facilities report lower TRIR rates, though most still exceed the industry averages. For instance, 2024 data shows TRIR rates 2.48 at McGregor, 3.49 at Bastrop, 1.43 at Hawthorne, 2.89 at the Redmond site. The 2024 TRIR for aerospace manufacturing as a whole is 1.6. SpaceX also operates several non-manufacturing sites, including barge operations off both coasts, offices in Sunnyvale, California, and launch sites at Cape Canaveral and Vandenberg Space Force Base. Former OSHA Chief of Staff Debbie Berkowitz told TechCrunch via email that Starbase's TRIR 'is a red flag that there are serious safety issues that need to be addressed.' However, there is a debate among safety professionals about whether TRIR is the most reliable metric for assessing and predicting injury rates, particularly serious incidents like fatalities, and especially for small companies. A recent paper on TRIR questioned its statistical validity and advocated that organizations use alternative measures of safety performance instead. Of the 14 OSHA inspections at SpaceX facilities over the past four years, six involved accidents and injuries at Starbase. That includes a partial finger amputation in 2021 and a crane collapse in June 2025. The latter inspection is still ongoing. Investigations by other news outlets including Reuters have uncovered hundreds of previously unreported worker injuries, including crushed limbs and one fatality. The 2024 injury rate at Starbase marks an improvement to that of the prior year, which topped out at 5.9 injuries per 100 workers in 2023 and 4.8 injuries in 2022. But it still leads among SpaceX's land-based facilities, and is second overall only to its west coast booster recovery operations, which has a TRIR of 7.6. OSHA confirmed TechCrunch's calculation of Starbase's TRIR over email, but otherwise did not respond to questions regarding that location's injury rate. SpaceX did not respond to request for comment. NASA's stake NASA has a major stake in Starship's development. The agency is counting on using the rocket to return humans to the Moon before the end of this decade, and it is paying more than $4 billion to SpaceX for two crewed Starship flights to the lunar surface. Both the contract for the Starship lander and SpaceX's contract for its Commercial Crew services to the International Space Station contain particular clauses that allow the agency to take action in the case of a major breach of safety, such as a fatality or a 'willful' or 'repeat' OSHA violation. While a persistently high TRIR rate can be evidence of a safety problem, it is not an automatic trigger for action, and does not fall under the definition of a 'major breach of safety' in their contracts. 'NASA interacts frequently with its partners, including SpaceX, to ensure safety from a mission assurance perspective, and remains in regular contact with the company during normal contract administration,' a NASA spokesperson told TechCrunch in response to questions about the company's TRIR. 'Safety is paramount to NASA's mission success. The agency continues to work with all our commercial partners to build and maintain a healthy safety culture.' Among rocket makers with vehicles in operation, Starbase still leads the pack: at ULA's manufacturing facility in Decatur, Alabama, the TRIR is 1.12 injuries per 100 workers; at Blue Origin's rocket park on the coast of Florida, the rate is 1.09. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data


TechCrunch
5 minutes ago
- TechCrunch
Starbase injury rates outpace rivals as SpaceX chases its Mars moonshot
SpaceX employees are more likely to be injured while working at Starbase than any of its other manufacturing facilities, according to company worker safety records reviewed by TechCrunch. Starbase, a sprawling launch-and-manufacturing site that recently incorporated as its own Texas city, logged injury rates almost six times higher than the average for comparable space vehicle manufacturing outfits and nearly three times higher than aerospace manufacturing as a whole in 2024, according to Occupational Safety and Health Administration (OSHA) data released in May. That outsized injury rate has persisted since 2019, when SpaceX began sharing Starbase injury data with the federal regulator. Starbase is home to SpaceX's most ambitious program: a fully reusable, ultra-heavy-lift rocket called Starship. The company has been moving at a breakneck pace to bring Starship online to launch Starlink internet satellites and other payloads. Since Starship's first orbital test in April 2023, SpaceX has attempted eight additional integrated flights. During three of those tests, the company made history by catching the massive Super Heavy booster with 'chopstick' arms attached to the launch tower. The data suggests that SpaceX's rapid progress comes at a cost. And while injury rates alone don't provide a complete picture of the safety culture at Starbase, they do offer a rare glimpse into the working conditions of the world's leading space company. Breaking down Starbase numbers Starbase City, an unincorporated town in Texas. Image Credits:SpaceX OSHA uses a standardized safety metric called Total Recordable Incident Rate (TRIR) to measure a company's safety record and compare it to industry peers, like Blue Origin and United Launch Alliance. The publicly available data has limitations. It doesn't distinguish between minor injuries like stitches versus serious incidents such as amputations. TechCrunch calculated the TRIR based on that data, which includes the total number of incidents and total number of hours worked by SpaceX employees at each site. Techcrunch event Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. San Francisco | REGISTER NOW Starbase, which plays a central role in SpaceX CEO Elon Musk's mission to make life multi-planetary, is an outlier in the company and across the industry as a whole. Its TRIR topped out at 4.27 injuries per 100 workers in 2024, when it employed an average of 2,690 workers, according to the data submitted to OSHA. Injured Starbase employees were unable to perform their normal job duties for a total of 3,558 restricted-duty days, plus 656 lost-time days where injuries made them unable to work at all. Starbase is classified by the U.S. government as a space vehicle manufacturing operation. The injury rate in this sector has fallen dramatically since 1994, dropping from 4.2 injuries per 100 workers to 0.7 injuries per 100 workers in 2023, according to historical data from the Bureau of Labor Statistics. (BLS calculates these rates through its annual company surveys, which asks for the same information found in OSHA's worker injury forms.) But despite major changes in safety processes across the industry, Starbase is closer to the rates of 30 years ago. The injury rate across all of SpaceX's manufacturing facilities — which includes an engine development and testing site in McGregor, Texas; a Starlink satellite manufacturing complex in Bastrop, Texas; the Falcon rocket complex in Hawthorne, California; and another satellite manufacturing site in Redmond, Washington — is 2.28. These other facilities report lower TRIR rates, though most still exceed the industry averages. For instance, 2024 data shows TRIR rates 2.48 at McGregor, 3.49 at Bastrop, 1.43 at Hawthorne, 2.89 at the Redmond site. The 2024 TRIR for aerospace manufacturing as a whole is 1.6. SpaceX also operates several non-manufacturing sites, including barge operations off both coasts, offices in Sunnyvale, California, and launch sites at Cape Canaveral and Vandenberg Space Force Base. Former OSHA Chief of Staff Debbie Berkowitz told TechCrunch via email that Starbase's TRIR 'is a red flag that there are serious safety issues that need to be addressed.' However, there is a debate among safety professionals about whether TRIR is the most reliable metric for assessing and predicting injury rates, particularly serious incidents like fatalities, and especially for small companies. A recent paper on TRIR questioned its statistical validity and advocated that organizations use alternative measures of safety performance instead. Of the 14 OSHA inspections at SpaceX facilities over the past four years, six involved accidents and injuries at Starbase. That includes a partial finger amputation in 2021 and a crane collapse in June 2025. The latter inspection is still ongoing. Investigations by other news outlets including Reuters have uncovered hundreds of previously unreported worker injuries, including crushed limbs and one fatality. The 2024 injury rate at Starbase marks an improvement to that of the prior year, which topped out at 5.9 injuries per 100 workers in 2023 and 4.8 injuries in 2022. But it still leads among SpaceX's land-based facilities, and is second overall only to its west coast booster recovery operations, which has a TRIR of 7.6. OSHA confirmed TechCrunch's calculation of Starbase's TRIR over email, but otherwise did not respond to questions regarding that location's injury rate. SpaceX did not respond to request for comment. NASA's stake NASA Crew-2 Mission in 2021 returns to Earth. Image Credits:SpaceX under a CC BY NC 2.0 license. NASA has a major stake in Starship's development. The agency is counting on using the rocket to return humans to the Moon before the end of this decade, and it is paying more than $4 billion to SpaceX for two crewed Starship flights to the lunar surface. Both the contract for the Starship lander and SpaceX's contract for its Commercial Crew services to the International Space Station contain particular clauses that allow the agency to take action in the case of a major breach of safety, such as a fatality or a 'willful' or 'repeat' OSHA violation. While a persistently high TRIR rate can be evidence of a safety problem, it is not an automatic trigger for action, and does not fall under the definition of a 'major breach of safety' in their contracts. 'NASA interacts frequently with its partners, including SpaceX, to ensure safety from a mission assurance perspective, and remains in regular contact with the company during normal contract administration,' a NASA spokesperson told TechCrunch in response to questions about the company's TRIR. 'Safety is paramount to NASA's mission success. The agency continues to work with all our commercial partners to build and maintain a healthy safety culture.' Among rocket makers with vehicles in operation, Starbase still leads the pack: at ULA's manufacturing facility in Decatur, Alabama, the TRIR is 1.12 injuries per 100 workers; at Blue Origin's rocket park on the coast of Florida, the rate is 1.09.


Associated Press
6 minutes ago
- Associated Press
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN ) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197) titled, 'Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models.' This patent covers technology developed by that leverages machine learning algorithms, powered by Microsoft (Nasdaq: MSFT ) and Databricks intended to rapidly and accurately identify peptides with strong immune system interactions. Identifying these peptides is critical in developing targeted therapies for a variety of diseases, including cancers and infectious diseases. Traditional methods for identifying immunologically active peptides often face significant limitations, such as overlooking critical human genetic diversity factors like age, sex, race, and ethnicity. proprietary approach may overcome these challenges by: 'I'm pleased with continued progress in strategically harnessing artificial intelligence in support of our cell therapy development,' said Dr. Ryan Saadi, Founder and CEO of Tevogen. 'Leveraging AI to accelerate discovery, shorten development timelines, and reduce costs is essential to our mission of delivering commercially attractive, economically viable, and cost-effective personalized T cell therapies.' Forward Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts Tevogen Bio Communications T: 1 877 TEVOGEN, Ext 701 [email protected]